State Legislature Considers Bill to Help Cap Costs for West Virginians with Diabetes
Living with diabetes is an expensive proposition. It is estimated that one in four health care dollars is spent on diabetes related issues. West Virginia took two steps forward in the 2020 legislative session to address high prescription drug costs for West Virginia families, both with bipartisan support:
- The legislature passed the “Requiring Accountable Pharmaceutical Transparency, Oversight, and Reporting Act” law which requires drug manufacturers and health benefit plan issuers who sell prescription drugs in West Virginia to provide cost information, changes in cost information, and prescription drug statistics to the State Auditor who will publish the data on a public website in June 2021.
- The legislature passed a private insurance insulin copayment cap of $100 per month.